|
Volumn 2, Issue 2, 2008, Pages 237-243
|
Prognostic analysis of pulmonary metastases from hepatocellular carcinoma
|
Author keywords
Hepatocellular carcinoma (HCC); Pulmonary metastases; Survival analysis
|
Indexed keywords
ALPHA FETOPROTEIN;
ANTINEOPLASTIC AGENT;
CISPLATIN;
DOXORUBICIN;
FLUOROURACIL;
GAMMA GLUTAMYLTRANSFERASE;
HEPATITIS B SURFACE ANTIGEN;
IODINATED POPPYSEED OIL;
MITOMYCIN C;
ADULT;
AGE DISTRIBUTION;
AGED;
ARTICLE;
CANCER DIAGNOSIS;
CANCER SURVIVAL;
CAUSE OF DEATH;
CHEMOEMBOLIZATION;
CONTINUOUS INFUSION;
CONTROLLED STUDY;
DISTANT METASTASIS;
FEMALE;
GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL;
HUMAN;
HUMAN TISSUE;
KAPLAN MEIER METHOD;
LIVER CELL CARCINOMA;
LIVER FAILURE;
LIVER FUNCTION;
LIVER TUMOR;
LUNG LESION;
LUNG METASTASIS;
LYMPH NODE METASTASIS;
MAJOR CLINICAL STUDY;
MALE;
OVERALL SURVIVAL;
PRIORITY JOURNAL;
PROGNOSIS;
PROPORTIONAL HAZARDS MODEL;
PROTEIN BLOOD LEVEL;
RESPIRATORY FAILURE;
RETROSPECTIVE STUDY;
RISK FACTOR;
SEX DIFFERENCE;
SURVIVAL TIME;
TUMOR CLASSIFICATION;
TUMOR THROMBUS;
TUMOR VOLUME;
|
EID: 57349145110
PISSN: 19360533
EISSN: 19360541
Source Type: Journal
DOI: 10.1007/s12072-008-9052-7 Document Type: Article |
Times cited : (36)
|
References (14)
|